DNTH · Categories · Form 4

DNTH - SEC Form 4 insider transactions

Dianthus Therapeutics Inc. (DNTH) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for DNTH

• 6d
  EVP, Head of R&D Randhawa Simrat exercised 26,530 shares at a strike of $18.85 and sold $2,404,077 worth of shares (26,530 units at $90.62) as part of a pre-agreed trading plan (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 17d
  SEC Form 4 filed by Director Lawton Alison Frances

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 17d
  SEC Form 4 filed by Director Romano Steven J.

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 17d
  SEC Form 4 filed by Director Mcgeorge Anne

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 17d
  SEC Form 4 filed by Director Read Simon

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 17d
  SEC Form 4 filed by Director Violin Jonathan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 17d
  SEC Form 4 filed by Director Soteropoulos Paula

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 17d
  SEC Form 4 filed by Director Kango Sujay

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 28d
  Director Soteropoulos Paula exercised 599 shares at a strike of $8.44 and sold $51,197 worth of shares (599 units at $85.47) as part of a pre-agreed trading plan (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 59d
  SEC Form 4 filed by Savitz Ryan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 68d
  SEC Form 4 filed by Savitz Ryan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 68d
  SEC Form 4 filed by Soteropoulos Paula

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 74d
  SEC Form 4 filed by Soteropoulos Paula

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 83d
  CEO AND PRESIDENT Garcia Marino exercised 65,292 shares at a strike of $7.66 (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 87d
  CHIEF ACCOUNTING OFFICER Carr Edward exercised 43,682 shares at a strike of $20.45 and sold $3,559,495 worth of shares (43,682 units at $81.49) (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 87d
  EVP, Head of R&D Randhawa Simrat exercised 33,830 shares at a strike of $18.15 and sold $2,756,468 worth of shares (33,830 units at $81.48) (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 87d
  CEO AND PRESIDENT Garcia Marino exercised 122,918 shares at a strike of $6.70 and sold $10,016,381 worth of shares (122,918 units at $81.49) (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 124d
  SEC Form 4 filed by CHIEF ACCOUNTING OFFICER Carr Edward

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 124d
  SEC Form 4 filed by SVP, General Counsel and Sec. Veness Adam M

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 124d
  SEC Form 4 filed by EVP, Head of R&D Randhawa Simrat

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 124d
  SEC Form 4 filed by EVP, CFO & CBO Savitz Ryan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 124d
  SEC Form 4 filed by CEO AND PRESIDENT Garcia Marino

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 185d
  CFO & CBO Savitz Ryan exercised 20,000 shares at a strike of $8.44 and sold $903,600 worth of shares (20,000 units at $45.18) (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 206d
  EVP, Head of R&D Randhawa Simrat exercised 196,538 shares at a strike of $15.25 and sold $7,379,887 worth of shares (196,538 units at $37.55) (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 248d
  SEC Form 4 filed by CEO AND PRESIDENT Garcia Marino

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 256d
  SEC Form 4 filed by CFO & CBO Savitz Ryan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 256d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Randhawa Simrat

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 270d
  CFO & CBO Savitz Ryan exercised 20,000 shares at a strike of $8.44 and sold $700,000 worth of shares (20,000 units at $35.00) (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 382d
  SEC Form 4 filed by Director Violin Jonathan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 382d
  SEC Form 4 filed by Director Soteropoulos Paula

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 382d
  SEC Form 4 filed by Director Romano Steven J.

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 382d
  SEC Form 4 filed by Director Mcgeorge Anne

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 382d
  SEC Form 4 filed by Director Lawton Alison Frances

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 382d
  SEC Form 4 filed by Director Read Simon

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 460d
  SEC Form 4 filed by Director Kango Sujay

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 489d
  SEC Form 4 filed by CHIEF ACCOUNTING OFFICER Carr Edward

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 489d
  SEC Form 4 filed by SVP, General Counsel and Sec. Veness Adam M

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 489d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Randhawa Simrat

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 489d
  SEC Form 4 filed by CFO & CBO Savitz Ryan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 489d
  SEC Form 4 filed by CEO AND PRESIDENT Garcia Marino

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 615d
  Director Fairmount Funds Management Llc disposed of 62,146 shares (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 628d
  SEC Form 4 filed by Director Romano Steven J.

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 741d
  SEC Form 4 filed by Carr Edward

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 741d
  SEC Form 4 filed by Veness Adam M

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 741d
  SEC Form 4 filed by Savitz Ryan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 741d
  SEC Form 4 filed by Randhawa Simrat

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 741d
  SEC Form 4 filed by Garcia Marino

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 741d
  SEC Form 4 filed by Violin Jonathan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 741d
  SEC Form 4 filed by Soteropoulos Paula

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 741d
  SEC Form 4 filed by Moulder Leon O Jr

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 741d
  SEC Form 4 filed by Mcgeorge Anne

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 741d
  SEC Form 4 filed by Lawton Alison Frances

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 741d
  SEC Form 4 filed by Fairmount Funds Management Llc

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 798d
  Fairmount Funds Management Llc disposed of 58,857 shares and acquired 58,857 shares (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)

Other DNTH categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends